News & Updates

Reduced exercise capacity at a young age appears to be associated with a higher likelihood of future cardiovascular events in paediatric patients with congenital heart defects (CHDs), according to a study.

New drug applications approved by US FDA as of 1-15 August 2024 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

The use of a powder agent, either as monotherapy or in combination with other conventional therapy, appears to be safe and effective for endoscopic haemostasis in children with acute upper gastrointestinal (GI) bleeding (UGIB), according to real-world data from Singapore.

Several products in the Southeast Asia (SEA) region that are being marketed for infants and young children are considered ultraprocessed and contain certain additives, reveals a recent study. In addition, many of these additives are banned by Codex Alimentarius.

Emodepside appears to be efficacious in the treatment of hookworm infections, with cure rates that surpass those achieved with albendazole but at the expense of increased adverse events (AEs), as shown in a phase IIb study.

New research suggests that the intensity of sunlight, not just the amount of time spent outdoors, is crucial for preventing myopia in children.

Among pregnant women, exposure to mRNA COVID-19 vaccine in the first trimester does not appear to contribute to an increased risk of selected major structural birth defects, according to a retrospective study.